866-997-4948(US-Canada Toll Free)

Albumin (as Excipient) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

Published By :

Transparency Market Research

Published Date : Jul 2017

Category :

Vaccines

No. of Pages : 212 Pages

Global Albumin (as Excipient) Market: Overview

This report analyzes the global albumin (as excipient) market in terms of its current and future business prospects. Grant of regulatory approvals and subsequent launch of albumin-based products, increasing participation from the pharmaceutical industry in the development and manufacturing of biopharmaceuticals, along with rise in research & development expenditure and increase in consumption of albumin are the key factors driving the growth of the global albumin (as excipient) market. Albumin serves as an important ingredient for formulated proteins and as a component of culture media and other biotech products, ultimately acting as a multifunctional excipient. Use of a well-characterized multifunctional excipient eliminates the time consumed during characterization of each excipient for different functions. This reduces the associated cost, shortens the registration process, and creates a faster route toward the market. Other factors, such as, decrease in issues with variability in quality, lower lot-to-lot and supplier-to-supplier variation, and reduction in the time involved in formulation optimization also drive the demand for albumin as excipient.

This report on albumin (as excipient) market comprises an elaborate executive summary, which includes a market snapshot, providing information on the various segments of the market. It also provides information and data analysis of the global market with respect to its segments based on product, application, end-user and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section of the report. In addition, it comprises competitive matrix and company profiles with business overview to understand the competition in the market. The section also provides market attractiveness analysis, by geography, and market share analysis, in terms of key players, thus presenting a thorough analysis of the overall competitive scenario in the albumin (as excipient) market.

Global Albumin (as Excipient) Market: Key Segments

In terms of product, the global albumin (as excipient) market has been segmented into human serum albumin and recombinant albumin. Based on application, the global market has been divided into human serum albumin applications and recombinant albumin applications. The human serum albumin application segment has further been classified into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizers, diagnostics, and in vitro fertilization. The recombinant albumin segment has further been bifurcated into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizers, diagnostics, and in vitro fertilization. Market size and forecast for each of these segments have been provided in terms of US$ Mn for the period of 2016 to 2026, along with their respective CAGRs, for the forecast period of 2018 to 2026, considering 2017 as the base year.

Global Albumin (as Excipient) Market: Regional Outlook

Geographically, the global albumin (as excipient) market has been categorized into four major regions and key countries in the respective regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia, and Rest of Asia Pacific), Rest of the World (Brazil, Mexico, South Africa, Saudi Arabia). Market size and forecast for each of these regions and countries have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period of 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario of the albumin (as excipient) market in these regions.

Companies Profiled in the Report

The report also profiles major players operating in the global albumin (as excipient) market based on various attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major players in the market are Albumedix A/S (Novozyme A/S), Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC, Grifols International, S.A, HiMedia Laboratories Pvt. Ltd., InVitria, Medxbio Pte Ltd, Octapharma AG, RayBiotech, Inc., SeraCare Life Sciences, and Sigma-Aldrich Co. (Merck KGaA).

The global albumin (as excipient) market has been segmented as given below:

  • Product
    • Human Serum Albumin
    • Recombinant Albumin
  • Application
    • Human Serum Albumin Applications
      • Drug Formulation
      • Drug Delivery
      • Vaccines
      • Medical Device Coating
      • Culture Medium & Stabilizer
      • Diagnostics
      • In Vitro Fertilization
    • Recombinant Albumin Applications
    • Serum Albumin Applications
      • Drug Formulation
      • Drug Delivery
      • Vaccines
      • Medical Device Coating
      • Culture Medium & Stabilizer
      • Diagnostics
      • In Vitro Fertilization
    • End-user
      • Pharmaceutical & Biotechnology Industry
      • Research Institutes
      • Others

Global Pediatric Health Care Products and Services Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Rest of the World

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Albumin (as Excipient) Market

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Albumin (as Excipient) Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume Shipments Projections
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Key Trends
5.2. Competition Landscape Analysis (Based on Recent Developments of Key Players)
5.3. Pricing Assessment, by Product Type

6. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value and Volume Forecast, by Product Type, 2016–2026
6.3.1. Human Serum Albumin
6.3.2. Recombinant Albumin
6.4. Market Attractiveness, by Product Type

7. Global Albumin (as Excipient) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value and Volume Forecast, by Application, 2016–2026
7.3.1. Human Serum Albumin Applications
7.3.1.1. Drug Formulation
7.3.1.2. Drug Delivery
7.3.1.3. Vaccines
7.3.1.4. Medical Device Coating
7.3.1.5. Culture Media & Stabilizers
7.3.1.6. Diagnostics
7.3.1.7. In Vitro Fertilization
7.3.2. Recombinant Albumin Applications
7.3.2.1. Drug Formulation
7.3.2.2. Drug Delivery
7.3.2.3. Vaccines
7.3.2.4. Medical Device Coating
7.3.2.5. Culture Media & Stabilizers
7.3.2.6. Diagnostics
7.3.2.7. In Vitro Fertilization
7.4. Market Attractiveness, by Application

8. Global Albumin (as Excipient) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2016–2026
8.3.1. Pharmaceutical & Biotechnology Industry
8.3.2. Research Institutes
8.3.3. Others
8.4. Market Attractiveness, by End-user

9. Global Albumin (as Excipient) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value and Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Rest of the World
9.3. Market Attractiveness, by Country/Region

10. North America Albumin (as Excipient) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value and Volume Forecast, by Product Type, 2016–2026
10.2.1. Human Serum Albumin
10.2.2. Recombinant Albumin
10.3. Market Value and Volume Forecast, by Application, 2016–2026
10.3.1. Human Serum Albumin Applications
10.3.1.1. Drug Formulation
10.3.1.2. Drug Delivery
10.3.1.3. Vaccines
10.3.1.4. Medical Device Coating
10.3.1.5. Culture Media & Stabilizers
10.3.1.6. Diagnostics
10.3.1.7. In Vitro Fertilization
10.3.2. Recombinant Albumin Applications
10.3.2.1. Drug Formulation
10.3.2.2. Drug Delivery
10.3.2.3. Vaccines
10.3.2.4. Medical Device Coating
10.3.2.5. Culture Media & Stabilizers
10.3.2.6. Diagnostics
10.3.2.7. In Vitro Fertilization
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Pharmaceutical & Biotechnology Industry
10.4.2. Research Institutes
10.4.3. Others
10.5. Market Value and Volume Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. by Product Type
10.6.2. by Application
10.6.3. by End-user
10.6.4. by Country

11. Europe Albumin (as Excipient) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value and Volume Forecast, by Product Type, 2016–2026
11.2.1. Human Serum Albumin
11.2.2. Recombinant Albumin
11.3. Market Value and Volume Forecast, by Application, 2016–2026
11.3.1. Human Serum Albumin Applications
11.3.1.1. Drug Formulation
11.3.1.2. Drug Delivery
11.3.1.3. Vaccines
11.3.1.4. Medical Device Coating
11.3.1.5. Culture Media & Stabilizers
11.3.1.6. Diagnostics
11.3.1.7. In Vitro Fertilization
11.3.2. Recombinant Albumin Applications
11.3.2.1. Drug Formulation
11.3.2.2. Drug Delivery
11.3.2.3. Vaccines
11.3.2.4. Medical Device Coating
11.3.2.5. Culture Media & Stabilizers
11.3.2.6. Diagnostics
11.3.2.7. In Vitro Fertilization
11.4. Market Value Forecast, by End-user, 2016–2026
11.4.1. Pharmaceutical & Biotechnology Industry
11.4.2. Research Institutes
11.4.3. Others
11.5. Market Value and Volume Forecast, by Country, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. by Product Type
11.6.2. by Application
11.6.3. by End-user
11.6.4. by Country

12. Asia Pacific Albumin (as Excipient) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value and Volume Forecast, by Product Type, 2016–2026
12.2.1. Human Serum Albumin
12.2.2. Recombinant Albumin
12.3. Market Value and Volume Forecast, by Application, 2016–2026
12.3.1. Human Serum Albumin Applications
12.3.1.1. Drug Formulation
12.3.1.2. Drug Delivery
12.3.1.3. Vaccines
12.3.1.4. Medical Device Coating
12.3.1.5. Culture Media & Stabilizers
12.3.1.6. Diagnostics
12.3.1.7. In Vitro Fertilization
12.3.2. Recombinant Albumin Applications
12.3.2.1. Drug Formulation
12.3.2.2. Drug Delivery
12.3.2.3. Vaccines
12.3.2.4. Medical Device Coating
12.3.2.5. Culture Media & Stabilizers
12.3.2.6. Diagnostics
12.3.2.7. In Vitro Fertilization
12.4. Market Value Forecast, by End-user, 2016–2026
12.4.1. Pharmaceutical & Biotechnology Industry
12.4.2. Research Institutes
12.4.3. Others
12.5. Market Value and Volume Forecast, by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. by Product Type
12.6.2. by Application
12.6.3. by End-user
12.6.4. by Country

13. Rest of the World Albumin (as Excipient) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value and Volume Forecast, by Product Type, 2016–2026
13.2.1. Human Serum Albumin
13.2.2. Recombinant Albumin
13.3. Market Value and Volume Forecast by Application, 2016–2026
13.3.1. Human Serum Albumin Applications
13.3.1.1. Drug Formulation
13.3.1.2. Drug Delivery
13.3.1.3. Vaccines
13.3.1.4. Medical Device Coating
13.3.1.5. Culture Media & Stabilizers
13.3.1.6. Diagnostics
13.3.1.7. In Vitro Fertilization
13.3.2. Recombinant Albumin Applications
13.3.2.1. Drug Formulation
13.3.2.2. Drug Delivery
13.3.2.3. Vaccines
13.3.2.4. Medical Device Coating
13.3.2.5. Culture Media & Stabilizers
13.3.2.6. Diagnostics
13.3.2.7. In Vitro Fertilization
13.4. Market Value Forecast, by End-user, 2016–2026
13.4.1. Pharmaceutical & Biotechnology Industry
13.4.2. Research Institutes
13.4.3. Others
13.6. Market Attractiveness Analysis
13.6.1. by Product Type
13.6.2. by Application
13.6.3. by End-user

14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2017)
14.3. Company Profiles
14.3.1. Albumedix A/S (Novozyme A/S)
14.3.1.1. Overview (HQ, Employee Strength, Business Segments)
14.3.1.2. Financials
14.3.1.3. Recent Developments
14.3.1.4. Strategy
14.3.2. Albumin Therapeutics, LLC
14.3.2.1. Overview (HQ, Employee Strength, Business Segments)
14.3.2.2. Financials
14.3.2.3. Recent Developments
14.3.2.4. Strategy
14.3.3. Biotest AG
14.3.3.1. Overview (HQ, Employee Strength, Business Segments)
14.3.3.2. Financials
14.3.3.3. Recent Developments
14.3.3.4. Strategy
14.3.4. CSL Behring LLC
14.3.4.1. Overview (HQ, Employee Strength, Business Segments)
14.3.4.2. Financials
14.3.4.3. Recent Developments
14.3.4.4. Strategy
14.3.5. Grifols International, S.A
14.3.5.1. Overview (HQ, Employee Strength, Business Segments)
14.3.5.2. Financials
14.3.5.3. Recent Developments
14.3.5.4. Strategy
14.3.6. HiMedia Laboratories Pvt. Ltd.
14.3.6.1. Overview (HQ, Employee Strength, Business Segments)
14.3.6.2. Financials
14.3.6.3. Recent Developments
14.3.6.4. Strategy
14.3.7. InVitria
14.3.7.1. Overview (HQ, Employee Strength, Business Segments)
14.3.7.2. Financials
14.3.7.3. Recent Developments
14.3.7.4. Strategy
14.3.8. Medxbio Pte Ltd.
14.3.8.1. Overview (HQ, Employee Strength, Business Segments)
14.3.8.2. Financials
14.3.8.3. Recent Developments
14.3.8.4. Strategy
14.3.9. Octapharma AG
14.3.9.1. Overview (HQ, Employee Strength, Business Segments)
14.3.9.2. Financials
14.3.9.3. Recent Developments
14.3.9.4. Strategy
14.3.10. RayBiotech, Inc.
14.3.10.1. Overview (HQ, Employee Strength, Business Segments)
14.3.10.2. Financials
14.3.10.3. Recent Developments
14.3.10.4. Strategy
14.3.11. SeraCare Life Sciences
14.3.11.1. Overview (HQ, Employee Strength, Business Segments)
14.3.11.2. Financials
14.3.11.3. Recent Developments
14.3.11.4. Strategy
14.3.12. Sigma-Aldrich Co. (Merck KGaA)
14.3.12.1. Overview (HQ, Employee Strength, Business Segments)
14.3.12.2. Financials
14.3.12.3. Recent Developments
14.3.12.4. Strategy

List of Table

Table 01: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 03: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application (Human Serum Albumin Applications), 2016–2026
Table 05: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application (Human Serum Albumin Applications), 2016–2026
Table 06: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application (Recombinant Albumin Applications), 2016–2026
Table 07: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application (Recombinant Albumin Applications), 2016–2026
Table 08: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 10: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Region, 2016–2026
Table 11: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 12: North America Albumin (as Excipient) Market Volume (kg) Forecast, by Country, 2016–2026
Table 13: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 14: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 15: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 16: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 17: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 18: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 19: North America Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2016–2026
Table 22: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 24: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 25: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 26: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 27: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 28: Europe Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 29: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Asia Pacific Albumin (as Excipient) Market Volume (kg) Forecast, by Country/Sub-region, 2016–2026
Table 31: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 32: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 33: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 34: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 35: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 36: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 37: Asia Pacific Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 38: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 39: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 40: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 41: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 42: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 43: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 44: Rest of the World Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026

List of Chart

Figure 01: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, 2016–2026
Figure 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, 2016–2026
Figure 03: Global Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 04: Global Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 05: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Human Serum Albumin, 2016–2026
Figure 06: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Recombinant Albumin, 2016–2026
Figure 07: Global Albumin (as Excipient) Market Value Share, by Application, 2017 and 2026
Figure 08: Global Albumin (as Excipient) Market Attractiveness, by Application, 2018–2026
Figure 09: Global Albumin (as Excipient) Market Value Share, by Application (Human Serum Albumin), 2017 and 2026
Figure 10: Global Albumin (as Excipient) Market Attractiveness, by Application (Recombinant Albumin), 2017 and 2026
Figure 11: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Formulation, 2016–2026
Figure 12: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Delivery, 2016–2026
Figure 13: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
Figure 14: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Device Coating, 2016–2026
Figure 15: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Culture Media & Stabilizers, 2016–2026
Figure 16: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2016–2026
Figure 17: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vitro Fertilization, 2016–2026
Figure 18: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Formulation, 2016–2026
Figure 19: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Delivery, 2016–2026
Figure 20: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
Figure 21: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Device Coating, 2016–2026
Figure 22: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Culture Media & Stabilizers, 2016–2026
Figure 23: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2016–2026
Figure 24: Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vitro Fertilization, 2016–2026
Figure 25: Global Albumin (as Excipient) Market Attractiveness, by Application (Human Serum Albumin), 2018 - 2026
Figure 26: Global Albumin (as Excipient) Market Attractiveness, by Application (Recombinant Albumin), 2018–2026
Figure 27: Global Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 28: Global Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
Figure 29: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Industry, 2016–2026
Figure 30: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Research Institutes, 2016–2026
Figure 31: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Others, 2016–2026
Figure 32: Global Albumin (as Excipient) Market Value Share Analysis, by Region, 2017 and 2026
Figure 33: Global Albumin (as Excipient) Market Attractiveness Analysis, by Region
Figure 34: North America Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 35: North America Albumin (as Excipient) Market Value Share, by Country, 2017 and 2026
Figure 36: North America Albumin (as Excipient) Market Attractiveness, by Country, 2018–2026
Figure 37: North America Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 38: North America Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 39: North America Albumin (as Excipient) Market Value Share, by Human Serum Albumin Application, 2017 and 2026
Figure 40: North America Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Application, 2018–2026
Figure 41: North America Albumin (as Excipient) Market Value Share, by Recombinant Albumin Application, 2017 and 2026
Figure 42: North America Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Application, 2018–2026
Figure 43: North America Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 44: North America Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
Figure 45: Europe Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 46: Europe Albumin (as Excipient) Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 47: Europe Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 48: Europe Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 49: Europe Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 50: Europe Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
Figure 51: Europe Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
Figure 52: Europe Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
Figure 53: Europe Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
Figure 54: Europe Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 55: Europe Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
Figure 56: Asia Pacific Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 57: Asia Pacific Albumin (as Excipient) Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 58: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 59: Asia Pacific Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 60: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 61: Asia Pacific Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
Figure 62: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
Figure 63: Asia Pacific Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
Figure 64: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
Figure 65: Asia Pacific Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 66: Asia Pacific Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
Figure 67: Rest of the World Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 68: Rest of the World Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
Figure 69: Rest of the World Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
Figure 70: Rest of the World Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
Figure 71: Rest of the World Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
Figure 72: Rest of the World Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
Figure 73: Rest of the World Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
Figure 74: Rest of the World Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
Figure 75: Rest of the World Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *